Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Evaluating the safety of new vaccines: summary of a workshop.

Ellenberg SS, Foulkes MA, Midthun K, Goldenthal KL.

Am J Public Health. 2005 May;95(5):800-7.

PMID:
15855455
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

What should an ideal vaccine postlicensure safety system be?

Griffin MR, Braun MM, Bart KJ.

Am J Public Health. 2009 Oct;99 Suppl 2:S345-50. doi: 10.2105/AJPH.2008.143081.

PMID:
19797747
[PubMed - indexed for MEDLINE]
3.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

PMID:
12825543
[PubMed - indexed for MEDLINE]
Free Article
4.

Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety.

Salmon DA, Moulton LH, Halsey NA.

Am J Public Health. 2004 Jun;94(6):947-50.

PMID:
15249296
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.

Ball R, Horne D, Izurieta H, Sutherland A, Walderhaug M, Hsu H.

Pediatrics. 2011 May;127 Suppl 1:S31-8. doi: 10.1542/peds.2010-1722F. Epub 2011 Apr 18. Review.

PMID:
21502249
[PubMed - indexed for MEDLINE]
Free Article
6.

Evaluating vaccine safety before and after licensure.

Clemens J.

Bull World Health Organ. 2000;78(2):218-9.

PMID:
10743289
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization.

Braun MM, Terracciano G, Salive ME, Blumberg DA, Vermeer-de Bondt PE, Heijbel H, Evans G, Patriarca PA, Ellenberg SS.

Pediatrics. 1998 Nov;102(5):E52.

PMID:
9794982
[PubMed - indexed for MEDLINE]
8.

Challenges in the development, licensure, and use of combination vaccines.

Postema AS, Myers MG, Breiman RF.

Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S261-6.

PMID:
11709757
[PubMed - indexed for MEDLINE]
Free Article
9.

Current status and future trends in vaccine regulation--USA.

Falk LA, Ball LK.

Vaccine. 2001 Feb 8;19(13-14):1567-72.

PMID:
11166876
[PubMed - indexed for MEDLINE]
10.

Vaccination policies and programs: the federal government's role in making the system work.

Schwartz B, Orenstein WA.

Prim Care. 2001 Dec;28(4):697-711, v.

PMID:
11739026
[PubMed - indexed for MEDLINE]
11.

The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.

Nguyen M, Ball R, Midthun K, Lieu TA.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:291-7. doi: 10.1002/pds.2323.

PMID:
22262619
[PubMed - indexed for MEDLINE]
12.

Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.

Kanesa-thasan N, Shaw A, Stoddard JJ, Vernon TM.

Pediatrics. 2011 May;127 Suppl 1:S16-22. doi: 10.1542/peds.2010-1722D. Epub 2011 Apr 18. Review.

PMID:
21502248
[PubMed - indexed for MEDLINE]
Free Article
13.

Victims of our own success: will immunization remain the paradigm of effective prevention? Grantmakers In Health.

[No authors listed]

Issue Brief (Grantmakers Health). 1999 Aug;(4):1-18.

PMID:
14556299
[PubMed - indexed for MEDLINE]
14.

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC.

Pediatrics. 1997 Jun;99(6):765-73.

PMID:
9164767
[PubMed - indexed for MEDLINE]
15.

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):4-27.

PMID:
11295590
[PubMed - indexed for MEDLINE]
16.

Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee.

Peter G, des Vignes-Kendrick M, Eickhoff TC, Fine A, Galvin V, Levine MM, Maldonado YA, Marcuse EK, Monath TP, Osborn JE, Plotkin S, Poland GA, Quinlisk MP, Smith DR, Sokol M, Soland DB, Whitley-Williams PN, Williamson DE, Breiman RF.

Pediatrics. 1999 Oct;104(4 Pt 1):942-50. Review.

PMID:
10506239
[PubMed - indexed for MEDLINE]
17.
18.

Combination vaccines.

Decker MD.

Prim Care. 2001 Dec;28(4):739-61, vi. Review.

PMID:
11739028
[PubMed - indexed for MEDLINE]
19.

Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002.

Chang ML, Vitek C, Esparza J; WHO-UNAIDS-CDC.

AIDS. 2003 Oct 17;17(15):W1-10.

PMID:
14523295
[PubMed - indexed for MEDLINE]
20.

Propelling novel vaccines directed against tuberculosis through the regulatory process.

Brennan MJ, Collins FM, Morris SL.

Tuber Lung Dis. 1999;79(3):145-51. Review.

PMID:
10656113
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk